---
name: OCT Clinical
slug: oct-clinicaltrials
site: cro
website_domain: oct-clinicaltrials.com
summary: OCT Clinical runs Phase I–IV and BE trials across Central and Eastern Europe, including first-in-human and post-authorization studies. Its network of principal investigators covers more than 1,600 medical sites. Headquartered in Germany.
tagline: Managing clinical trials in Eastern Europe
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: DD
tier2_domain_verified: false
updated_at: 2026-11-22T07:02:48.831Z
services_count: 10
modalities_count: 0
indications_count: 5
locations_count: 20
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# OCT Clinical

Managing clinical trials in Eastern Europe

Listed on cro.directory.

## Summary

OCT Clinical runs Phase I–IV and BE trials across Central and Eastern Europe, including first-in-human and post-authorization studies. Its network of principal investigators covers more than 1,600 medical sites. Headquartered in Germany.

## At a glance

- HQ country: DD

## Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs

## Indications

- Oncology
- Neurology
- Psychiatry
- Infectious Disease
- Gastroenterology

## Locations

- Germany (HQ), Germany
- Latvia, Latvia
- Poland, Poland
- Romania, Romania
- Hungary, Hungary
- Czech Republic, Czech Republic
- Spain, Spain
- Bulgaria, Bulgaria
- Turkey, Turkey
- Brazil, Brazil
- Netherlands, Netherlands
- Georgia, Georgia
- Estonia, Estonia
- Lithuania, Lithuania
- Belarus, Belarus
- Serbia, Serbia
- Kazakhstan, Kazakhstan
- Croatia, Croatia
- Moldova, Moldova
- Switzerland, Switzerland

## Long description

## Overview

OCT Clinical is a contract research organization (CRO) focused on managing clinical trials in Central and Eastern Europe. The company describes its operations as spanning 21 countries and states that it has delivered high-quality CRO services since 2005.

## Clinical trial services

- Full-service clinical research for Phase I–IV and BE studies, including study design, regulatory support, site management, data management and biostatistics.
- Standalone services as well as full-service engagements.
- Clinical study design preparation, consulting and regulatory support, drug safety and pharmacovigilance, project management and monitoring, clinical data management, biostatistics, and clinical supply services and logistics.

## Experience and reach

- First-in-human trials in Central and Eastern Europe, in healthy volunteers and patients, working with early-stage research centers.
- Pivotal Phase II/III trials in the region.
- More than 25 post-authorization clinical trials, covering both interventional and non-interventional (pharmacoepidemiology) studies.
- Experience with 300 projects across many therapeutic areas.
- Access to a network of principal investigators at more than 1,600 medical sites.

## Therapeutic focus

Therapeutic areas named on the site include oncology, gastroenterology, rheumatology and infectious diseases. Excerpts also note that many studies in Latvia fall within oncology, neurology, psychiatry and endocrinology.

The website states that OCT has merged with Palleos Healthcare to form a wider European CRO.

## Similar companies

- [BioAgile Therapeutics](/companies/bioagiletherapeutics) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/bioagiletherapeutics/oct-clinicaltrials)
- [Linical](/companies/linical) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/linical/oct-clinicaltrials)
- [JSS Medical Research](/companies/jssresearch) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/jssresearch/oct-clinicaltrials)
- [Advanced Clinical](/companies/advancedclinical) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/advancedclinical/oct-clinicaltrials)
- [Krescent Medical Research](/companies/krescentmr) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/krescentmr/oct-clinicaltrials)
- [PharPoint Research](/companies/pharpoint) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/oct-clinicaltrials/pharpoint)
- [ProRelix Research](/companies/prorelixresearch) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/oct-clinicaltrials/prorelixresearch)
- [ExperTrials](/companies/expertrials) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/expertrials/oct-clinicaltrials)

_Profile last updated: 2026-11-22T07:02:48.831Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.